MMprofiler for Multiple Myeloma (PROMMIS Trial)

Recruiting in Palo Alto (17 mi)

+8 other locations

Overseen BySaad Usmani, MD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: SkylineDx

No Placebo Group

Trial Summary

What is the purpose of this trial?This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment intention decisions in Multiple Myeloma patients.

Eligibility Criteria

This trial is for individuals who may have multiple myeloma based on IMWG criteria and are candidates for systemic treatment. Participants must be able to perform daily activities with relative ease (ECOG Performance Status ≤ 3). They cannot join if their tumor samples fail quality assessments for the MMprofiler test.

Exclusion Criteria

I am mostly bedridden due to my health condition.

Participant Groups

The study is examining how the MMprofiler, which analyzes a specific gene signature in multiple myeloma patients, affects doctors' decisions about treatment plans. It's an observational study focusing on whether this genetic test influences treatment strategies.

1Treatment groups

Experimental Treatment

Group I: MMprofiler SKY92Experimental Treatment1 Intervention

Eligible patients will have their bone marrow biopsy sample analyzed for the prognostic MMprofiler SKY92 gene signature